Program Description: This two and a half day program will explore the economics and legal issues of the pharmaceutical industry and discuss many issues of importance to states. The conference will begin with foundational lectures on the economics of pharmaceutical pricing and understanding the FDA drug approval process. Conference panels will examine pharmaceutical marketing, False Claim Act litigation and Medicaid, consumer protection issues under the Affordable Care Act, concerns surrounding pharmaceuticals and intellectual property, as well as counterfeit drugs and consumer health.
Agenda
How the Pharmaceutical Industry Works: From Research to Drug to Market
Scott Gottlieb, Resident Fellow, American Enterprise Institute for Public Policy Research
The Economics of Pharmaceutical Pricing
Robert B. Helms, Resident Scholar, American Enterprise Institute for Public Policy Research
Pharmaceutical Marketing: Economic and Legal Issues
Richard Manning, Partner, Bates White Economics Consulting, Washington, DC
Theodora McCormick, Member, Epstein Becker and Green
James C. Stansel, Partner, Sidley Austin LLP
James M. “Mit” Spears, Executive Vice President and General Counsel, Pharmaceutical Research and Manufacturers of America
Wells Wilkinson, Staff Attorney and Senior Policy Analyst, Community Catalyst
Moderator: Michael D. Shumsky, Partner, Kirkland & Ellis, LLP
Fortress and Frontier in American Health Care
Robert F. Graboyes, Senior Research Fellow, Mercatus Center at George Mason University
Counterfeit Drugs and Consumer Health
Thomas T. Kubic, President & CEO, Pharmaceutical Security Institute
Matthew J. Bassiur, Vice President & Deputy Chief Security Officer, Pfizer Inc.
Moderator: Richard O. Faulk, Senior Director, Energy and the Environment, Law & Economics Center and Partner, Hollingsworth LLP
Consumer Protection Issues Under the Affordable Care Act
Leonardo Cuello, Director, Health Policy, National Health Law Program
Kathryn G. Chandra, State Policy Manager Government Affairs, Genentech
Moderator: Karen M. Czarnecki, Director, Education, Law & Economics Center
Understanding the FDA Drug Approval Process
Scott M. Lassman, Resident Scholar, American Enterprise Institute for Public Policy Research
Prescription Drug Abuse
Joshua M. Bolin, Director of Government Affairs, National Association of Board of Pharmacy
Robert Twillman, Executive Director, American Academy of Pain Management
Stephen J. Pasierb, President and CEO, Partnership for Drug-Free Kids
Moderator: Mitchel T. Denham, Assistant Deputy Attorney General, Office of the Kentucky Attorney General
False Claims Act Litigation and Medicaid
Jessica L. Ellsworth, Partner Hogan Lovells
William J. Cople, III, Partner, Hollingsworth LLP
Erica J. Bailey, Assistant Attorney General, Commonwealth of Virginia
Moderator: Stephen D. Rosenthal, former Virginia Attorney General and Partner, Troutman Sanders
For More Information, Contact: AGEP
703.993.9964
AGEP@gmu.edu